<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03052231</url>
  </required_header>
  <id_info>
    <org_study_id>LandonPF</org_study_id>
    <nct_id>NCT03052231</nct_id>
  </id_info>
  <brief_title>Interactive Mobile Health Information to Enhance Patient Care at a Cystic Fibrosis Center</brief_title>
  <acronym>MOMMI3CFCM</acronym>
  <official_title>Evaluating the Feasibility of Interactive Mobile Health Information to Enhance Patient Care at a Cystic Fibrosis Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Landon Pediatric Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AbbVie</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Landon Pediatric Foundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Real-world adherence to inhaled and oral therapies for cystic fibrosis (CF) patients remains
      discouragingly low, ranging between 31-53% for inhaled antibiotics and 41-72% for hypertonic
      saline. Programs to enhance adherence, including comprehensive behavioral interventions with
      adolescents, have met with mixed success. Advances in therapy, treatment delivery systems,
      and data capture technology offer the potential for enhancing adherence by providing
      immediate and more frequent feedback to the patient regarding his or her fidelity to the
      prescribed treatment regimen. The investigators propose to evaluate a systematic yet
      technically simple approach to linking treatment and feedback components to enhance adherence
      in a real-work CF clinic setting that treats a significant minority patient population.

      This is the first trial assessing the impact of a collaborative active intervention program
      of a multi disciplinary team in improving adherence to specific chronic medications and
      improving clinical outcomes in CF patients. The PI has implemented the texting service
      (Caremessage.org) with COPD and diabetes patients. The content will be modified to provide
      both English and Spanish language content relevant to these participants and their standard
      treatment protocols.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will evaluate the effectiveness of an interactive mobile health information
      service in supporting clinic staff (i.e., nurse practitioners, case managers and care
      coordinators) at a Cystic Fibrosis Center clinic to connect with patients and create
      conversations around behavior-centered goals. The interactive mobile health information
      service has been designed to supplement the standard of care by supporting
      patient-empowerment strategies through:

        -  educating participants,

        -  encouraging behavior change, and

        -  promoting adherence with their treatment protocols.

      The project will adapt the iCAN program content as an educational tool to be incorporated in
      the educational material. iCAN is an electronic platform aimed to provide an engaging
      environment for diabetic outpatients to self-manage, gain control over their health, and
      ultimately adhere to their medical appointments and regimen. Similar to diabetes, CF is an
      all-encompassing chronic disease that requires coordinated efforts among patients,
      caregivers, and health-care providers across treatment adherence, nutrition, lifestyle
      choices, and social support systems. Central to the mobile health information service is the
      interactive and personalized text-based message system that delivers actionable and tailored
      health content to participants: office visit appointment reminders; medication adherence
      reminders; and general health education messages. While a number of technically sophisticated
      applications exist, our approach will involve a less sophisticated and complex approach. Our
      primary objective is to get the information to the patients, some of whom are members of
      lower income minority communities. If &quot;simple&quot; interventions prove effective, then the
      groundwork will have been laid for considering more tailored albeit complex systems.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Scheduled appointments attended</measure>
    <time_frame>Six months</time_frame>
    <description>Secondary objectives include evaluating program processes that enhance participant use of the system: 1) to receive responses to specific questions; 2) to track their individual progress towards achieving health goals, and; 3) to respond to system prompts to self-report data in the interactive component related to their actions or behaviors, e.g. RSVP to appointment reminders, self-management behaviors related to medication adherence, and self-management behaviors related to the achieving health goals. Processes involving program management and impact on barriers to treatment delivery by clinic staff, treating physicians and parents will also be evaluated.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knowledge of disease Questionnaire</measure>
    <time_frame>Six Months</time_frame>
    <description>Secondary objectives include evaluating program processes that enhance participant use of the system: 1) to receive responses to specific questions; 2) to track their individual progress towards achieving health goals, and; 3) to respond to system prompts to self-report data in the interactive component related to their actions or behaviors, e.g. RSVP to appointment reminders, self-management behaviors related to medication adherence, and self-management behaviors related to the achieving health goals. Processes involving program management and impact on barriers to treatment delivery by clinic staff, treating physicians and parents will also be evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FEV1 in LPM</measure>
    <time_frame>6 months</time_frame>
    <description>Measure of pulmonary function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>six months</time_frame>
    <description>kg/meters squared</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Medication Adherence</condition>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>Interactive Mobile Health Information</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Receives Interactive Mobile Health Information via caremessage. EAI staff focus group content will include qualitative descriptions of their experiences with training and actual use of the Caremessages.org service, as well as to elicit comments about contributing features and other mitigating or enhancing factors of the intervention's implementation, outreach and promotion, and integration into workflow practices.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care - clinic education, medication refills without reminders, appointments without reminders</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>caremessage</intervention_name>
    <description>Central to the mobile health information service is the interactive and personalized text-based message system that delivers actionable and tailored health content to participants: office visit appointment reminders; medication adherence reminders; and general health education messages.</description>
    <arm_group_label>Interactive Mobile Health Information</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with diagnosis of Cystic fibrosis at all ages;

          -  Their associated CF Center professionals;

          -  Their associated family;

          -  CF patients that should be treated with one or more of these chronic medications: Tobi
             (Tobramycin), (Colistin), Pulmozyme (Dornase Alpha), Hypertonic Saline (HS), Creon
             (pancreatic enzymes), AquaADEKs (Multivitamin);

          -  Patients willing to participate in a trial;

          -  Presence of a parent/guardian capable of providing informed consent; and

          -  Patients attending CF clinic at least once every 12 months.

        Exclusion Criteria:

          -  Absence of a parent/guardian or unwillingness to provide permission;

          -  Potential participant declines to provide assent; and

          -  Transplant patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chris Landon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Landon Pediatric Foundation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pediatric Diagnostic Center</name>
      <address>
        <city>Ventura</city>
        <state>California</state>
        <zip>93003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Eakin MN, Bilderback A, Boyle MP, Mogayzel PJ, Riekert KA. Longitudinal association between medication adherence and lung health in people with cystic fibrosis. J Cyst Fibros. 2011 Jul;10(4):258-64. doi: 10.1016/j.jcf.2011.03.005. Epub 2011 Mar 31.</citation>
    <PMID>21458391</PMID>
  </reference>
  <reference>
    <citation>Quittner A et al. Chest 2011 (4_MeetingAbstracts):908A</citation>
  </reference>
  <reference>
    <citation>Imperial College of London. iCAN Self--‚ÄêManagement Technology: Helping Patients to Medical Appointments. CID 00884448, May 5, 2014</citation>
  </reference>
  <reference>
    <citation>Modi AC, Lim CS, Yu N, Geller D, Wagner MH, Quittner AL. A multi-method assessment of treatment adherence for children with cystic fibrosis. J Cyst Fibros. 2006 Aug;5(3):177-85. Epub 2006 May 5.</citation>
    <PMID>16679071</PMID>
  </reference>
  <reference>
    <citation>Taddeo D, Egedy M, Frappier JY. Adherence to treatment in adolescents. Paediatr Child Health. 2008 Jan;13(1):19-24.</citation>
    <PMID>19119348</PMID>
  </reference>
  <reference>
    <citation>QSR International, Victoria, Australia, 2015</citation>
  </reference>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 24, 2015</study_first_submitted>
  <study_first_submitted_qc>February 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 14, 2017</study_first_posted>
  <last_update_submitted>April 6, 2018</last_update_submitted>
  <last_update_submitted_qc>April 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>adherence</keyword>
  <keyword>cystic fibrosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Share with iCAN</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

